Stevanato Group S.p.A. (STVN) Stock Price

STVNStock

$18.90−21.58%52W

Market Cap$5.16B

P/E32.83x

PEG Ratio1.35

Div yield0.21%

Beta0.77

STVN Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)18.06%

Price vs S&P 500 (4W)-10.81%

PEG Ratio1.35

VGM Score47.26

P/E Ratio (Annual)32.83x

Indicated Dividend Yield (Annual)0.21%

P/CF (Annual)16.05x

Book Value / Share (Quarterly)$6.37

P/TBV (Annual)3.37x

Indicated Dividend (Annual)$0.07

Revenue Growth (3Y)6.44%

Cash Flow / Share (Quarterly)$-0.13

Payout Ratio (TTM)18.07%

Price vs S&P 500 (YTD)-17.99%

Gross Margin (TTM)29.94%

Net Profit Margin (TTM)10.99%

EPS (TTM)$0.55

10-Day Avg Trading Volume0.34M

EPS Excl Extra (TTM)$0.55

Revenue Growth (5Y)12.37%

EPS (Annual)$0.58

Dividend / Share (Annual)$0.06

ROI (Annual)7.15%

Gross Margin (Annual)29.60%

Net Profit Margin (5Y Avg)13.26%

Cash / Share (Quarterly)$0.38

P/E Basic Excl Extra (TTM)34.11x

Revenue Growth QoQ (YoY)7.86%

EPS Growth (5Y)13.98%

P/E Normalized (Annual)32.83x

ROA (Last FY)5.50%

Revenue Growth TTM (YoY)7.00%

EBITD / Share (TTM)$0.87

ROE (5Y Avg)12.19%

Operating Margin (TTM)16.37%

Cash Flow / Share (Annual)$0.05

P/B Ratio2.96x

P/B Ratio (Quarterly)3.14x

Net Income / Employee (Annual)$26,154

EV / Revenue (TTM)4.04x

Net Interest Coverage (TTM)20.90x

ROA (TTM)5.30%

EPS Growth QoQ (YoY)-22.70%

EV / EBITDA (TTM)23.31x

EPS Incl Extra (Annual)$0.58

Current Ratio (Annual)1.76x

Quick Ratio (Quarterly)1.08x

3-Month Avg Trading Volume0.37M

52-Week Price Return-21.58%

EV / Free Cash Flow (Annual)448.67x

P/E Incl Extra (TTM)34.11x

Revenue / Employee (TTM)$228,880

Tangible BV / Share (Quarterly)$6.21

P/S Ratio (Annual)3.87x

Asset Turnover (Annual)0.47x

52-Week High$31.42

Operating Margin (5Y Avg)17.73%

EPS Excl Extra (Annual)$0.58

CapEx CAGR (5Y)23.43%

26-Week Price Return27.96%

Quick Ratio (Annual)1.26x

13-Week Price Return-1.41%

Total Debt / Equity (Annual)0.32x

Current Ratio (Quarterly)1.61x

Enterprise Value$5.56B

Revenue / Share Growth (5Y)14.12%

Asset Turnover (TTM)0.48x

Revenue / Employee (Annual)$221,583

Inventory Turnover (Annual)3.25x

Pretax Margin (Annual)15.94%

Cash / Share (Annual)$0.54

3-Month Return Std Dev32.38%

Gross Margin (5Y Avg)31.00%

Net Income / Employee (TTM)$25,144

EBITDA CAGR (5Y)13.56%

EBITDA Interim CAGR (5Y)-3.36%

ROE (Last FY)9.41%

Net Interest Coverage (Annual)19.54x

EPS Basic Excl Extra (Annual)$0.58

P/FCF (TTM)962.51x

Receivables Turnover (TTM)2.76x

EV / Free Cash Flow (TTM)412.96x

Total Debt / Equity (Quarterly)0.29x

EPS Incl Extra (TTM)$0.55

Receivables Turnover (Annual)2.44x

ROI (TTM)6.89%

P/S Ratio (TTM)3.75x

Pretax Margin (5Y Avg)17.33%

Revenue / Share (Annual)$4.88

Tangible BV / Share (Annual)$5.96

Forward P/E27.10x

Free OCF CAGR (5Y)-28.64%

Price vs S&P 500 (52W)-37.11%

P/E Ratio (TTM)34.11x

EPS Growth TTM (YoY)0.28%

Year-to-Date Return-6.06%

5-Day Price Return-1.77%

EPS Normalized (Annual)$0.58

ROA (5Y Avg)7.13%

Net Profit Margin (Annual)11.79%

Month-to-Date Return-9.91%

Cash Flow / Share (TTM)$1.01

EBITD / Share (Annual)$0.87

EPS Growth (3Y)-1.71%

Operating Margin (Annual)16.76%

LT Debt / Equity (Annual)0.23x

P/CF (TTM)18.46x

ROI (5Y Avg)8.81%

P/E Excl Extra (TTM)34.11x

LT Debt / Equity (Quarterly)0.20x

EPS Basic Excl Extra (TTM)$0.55

P/TBV (Quarterly)3.22x

Payout Ratio (Annual)10.54%

P/B Ratio (Annual)3.29x

Dividend / Share (TTM)$0.06

Inventory Turnover (TTM)2.94x

Pretax Margin (TTM)15.69%

Book Value / Share (Annual)$6.11

Price vs S&P 500 (13W)-4.09%

Net Margin Growth (5Y)-0.12%

Dividend Yield (TTM)0.32%

Beta0.77x

P/FCF (Annual)415.68x

Revenue / Share (TTM)$5.04

ROE (TTM)8.97%

52-Week Low$14.47

vGradeD

gGradeC

mGradeC

vgmGradeC

STVN Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 4, 2026	$0.16	$0.18	+9.85%(+$0.01)
Q1 2026	May 7, 2026	$0.13	$0.15	+7.71%(+$0.01)
Q4 2025	Mar 4, 2026	$0.22	$0.23	+6.89%(+$0.01)
Q3 2025	Nov 6, 2025	$0.16	$0.18	+10.46%(+$0.02)
Q2 2025	Aug 5, 2025	$0.14	$0.14	+5.51%(+$0.01)

STVN Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.18

4.17

Industry Peers — Surgical & Medical Instruments(142)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
STVNStevanato Group S.p.A.	D	C	C	3.7x	12.4%	29.9%	16.4%	$18.90
SYKStryker Corporation	C	B	C	4.4x	11.8%	65.3%	21.3%	$294.66
MMM3M Company	C	D	B	3.4x	-5.0%	39.4%	18.4%	$164.75
BSXBoston Scientific Corp.	C	B	C	3.1x	15.2%	69.5%	19.8%	$44.39
BDXBecton, Dickinson and Co.	B	D	A	2.5x	6.3%	46.7%	9.6%	$191.75
MDLNMedline Inc. Class A common stock	C	D	C	1.6x	—	26.2%	6.0%	$35.96
RMDResMed Inc.	C	C	B	5.9x	12.1%	61.1%	33.4%	$238.97
DXCMDexCom, Inc.	C	B	B	6.5x	19.3%	64.3%	22.9%	$86.04
WSTWest Pharmaceutical Services, Inc.	D	C	A	8.5x	7.4%	36.8%	20.4%	$384.02
SOLVSolventum Corporation	C	C	B	1.8x	—	54.8%	23.9%	$85.81
BAXBaxter International Inc.	B	D	B	1.1x	-0.8%	30.7%	-2.3%	$25.28
PENPenumbra, Inc.	F	C	B	8.4x	20.2%	67.8%	12.4%	$320.86
GMEDGLOBUS MEDICAL INC	B	B	B	3.3x	30.1%	68.5%	20.6%	$76.71
PODDInsulet Corporation	C	A	C	3.2x	24.5%	71.1%	16.9%	$141.10
GKOSGlaukos Corporation	F	A	B	15.9x	17.7%	79.1%	-31.6%	$164.84
TFXTeleflex Incorporated	B	F	B	2.1x	-4.7%	53.8%	-11.7%	$130.43
HAEHaemonetics Corporation	C	C	A	4.0x	8.9%	59.1%	11.9%	$118.28
MMSIMerit Medical Systems Inc	C	B	B	3.4x	9.5%	49.5%	12.8%	$89.20
MMEDMiniMed Group, Inc. Common Stock	—	—	B	—	—	—	—	$17.49
HTFLHeartflow, Inc. Common Stock	F	A	A	19.8x	—	80.1%	-40.8%	$48.29
ICUIICU Medical Inc	C	D	B	1.9x	11.9%	39.1%	3.5%	$162.99
IRTCiRhythm Holdings, Inc. Common Stock	D	B	C	4.3x	23.0%	71.5%	-3.0%	$108.66
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	2725.9x	—	0.3%	-7007.8%	$44.43
ATRCAtriCure, Inc.	D	B	A	5.0x	20.9%	76.3%	2.3%	$56.07
UFPTUFP Technologies Inc	C	B	A	3.6x	27.4%	28.5%	15.3%	$291.67
INSPInspire Medical Systems, Inc.	B	B	B	2.2x	51.2%	86.1%	6.0%	$68.79
LMATLeMaitre Vascular, Inc.	C	B	C	7.0x	14.0%	72.9%	29.5%	$80.82
NVCRNovoCure Limited Ordinary Shares	D	C	C	2.3x	5.8%	76.1%	-22.1%	$14.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	15.2x	—	53.9%	-140.4%	$27.24
ATECAlphatec Holdings, Inc.	D	B	C	2.0x	39.5%	70.8%	-7.5%	$10.46
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	B	—	—	—	—	$12.29
TNDMTandem Diabetes Care, Inc.	D	C	C	1.1x	15.3%	56.0%	-4.4%	$16.24
IRMDiRadimed Corporation	D	B	B	13.1x	21.4%	75.9%	31.9%	$88.27
AORTArtivion, Inc.	C	C	C	2.3x	11.8%	64.4%	2.9%	$21.78
IARTIntegra LifeSciences Holdings	B	F	C	0.6x	3.6%	57.2%	4.0%	$13.21
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	3.0x	109.0%	64.2%	-33.9%	$17.57
BVSBioventus Inc. Class A Common Stock	B	C	A	1.9x	12.1%	68.7%	10.0%	$13.30
BBNXBeta Bionics, Inc. Common Stock	D	A	C	7.4x	—	58.3%	-69.8%	$16.35
SIBNSI-BONE, Inc. Common Stock	D	B	B	4.1x	22.3%	79.5%	-8.3%	$19.68
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	—	—	—	—	$24.00
MDXGMiMedx Group, Inc	C	D	C	1.8x	11.0%	78.8%	2.5%	$4.43
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	2.3x	27.2%	73.7%	-11.9%	$21.95
TCMDTactile Systems Technology, Inc.	B	B	B	1.5x	12.0%	51.9%	10.0%	$22.52
SSIISS Innovations International Inc. Common Stock	F	A	D	9.7x	—	47.6%	-16.2%	$2.53
DCTHDelcath Systems Inc	D	C	B	5.1x	120.1%	87.0%	-1.9%	$14.08
ANGOAngioDynamics, Inc.	C	D	C	1.5x	1.9%	55.6%	-11.2%	$11.24
BWAYBrainsway Ltd. American Depositary Shares	D	B	B	9.5x	12.2%	74.9%	5.8%	$11.44
SGHTSight Sciences, Inc. Common Stock	D	B	A	5.5x	22.9%	88.4%	-33.4%	$8.28
CERSCerus Corp	D	C	C	1.8x	15.4%	57.2%	-0.7%	$2.18
NPCENeuropace, Inc. Common Stock	D	C	C	4.3x	19.4%	79.6%	-15.3%	$12.24
RCELAvita Medical, Inc. Common Stock	D	C	A	5.3x	19.6%	82.1%	-46.6%	$13.04

About Stevanato Group S.p.A.

Stevanato Group provides integrated drug containment, delivery, and diagnostic solutions throughout the pharmaceutical and biotechnology industries' product life cycles, spanning development, clinical, and commercial stages. The company operates through two segments: Biopharmaceutical and Diagnostic Solutions, which generates the majority of revenue, and Engineering. Stevanato derives most of its revenue from Europe, the Middle East, and Africa.

STVN Next Earnings Report

Report dateNov 5, 2026

QuarterQ3 2026

Report timeBMO

EPS estimate$0.20

Revenue estimate$359.96M

Also reporting on Nov 5, 2026

Scheduled date with consensus estimates — both can change before the company reports.

Earnings calendar for November 2026

STVN Insider Transactions

SellSep 28, 2026
STOCCHI MAURO
Officer
Shares: 13,649Value: $293,454
SellAug 7, 2026
DAL LAGO MARCO
Chief Financial Officer
Shares: 4,209Value: $84,559
SellAug 7, 2026
MAGISTRETTI ELISABETTA
Director
Shares: 2,045Value: $41,084
SellAug 7, 2026
SANTEL LUCIANO
Director
Shares: 2,023Value: $40,642

Open-market buys and sells filed with the SEC over the last 90 days. Grants, gifts and option exercises are excluded.

All insider transactions for September 2026

Companies in Related Industries

MSAMine Safety IncorporatedOrthopedic & Prosthetic Devices
CAMTCamtek LtdOptical Instruments & Lenses
STSensata Technologies Holding plcIndustrial Instruments
BLCOBausch + Lomb CorporationOphthalmic Goods
VNTVontier CorporationFluid Meters
ITGRInteger Holdings CorporationElectromedical Equipment
LIVNLivaNova PLC Ordinary SharesElectromedical Equipment
MIRMirion Technologies, Inc.Measuring & Controlling Devices

Same SIC sector, outside this company's own industry.

Analyst Sentiment

4.2

Buy

Consensus rating

52-Week Range

Low$14.47

High$31.42